January 30, 2017January 30, 2017

EU Approval of Humira Biosimilar, ABP501, to Treat Adults and Children with IBD Favored

News

ABP501, a biosimilar of Humira (adalimumab), was recommended for approval in the European Union to treat adults and some children with various inflammatory diseases, including inflammatory bowel disease (IBD), by the Committee for Medicinal ... Read more

September 27, 2016

U.S. FDA Approves Biosimilar Amjevita for Multiple Inflammatory Diseases

News

The Division of Drug Information at the U.S. Food and Drug Administration (FDA) has announced its approval of Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for the treatment of multiple ... Read more